Mode
Text Size
Log in / Sign up
Phase 4 N=1,409 Randomized Single-blind Treatment

Post-Discharge Smoking Cessation Strategies: Helping HAND 4

Smoking Cessation

Enrolled (actual)
1,409
Serious AEs
Results posted
May 2022
Primary outcome: Primary: Tobacco Abstinence, Biochemically Confirmed — 110; 96 Participants — p=.19

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
Transitional Tobacco Care Management (TTCM) (Behavioral); eReferral to State Tobacco Quitline (QL) (Behavioral); Nicotine replacement therapy (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Massachusetts General Hospital
Primary completion
Nov 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Tobacco Abstinence, Biochemically Confirmed
110; 96 .19
SECONDARY
Tobacco Abstinence, Self-report
234; 202 .079
SECONDARY
Tobacco Abstinence, Self-report
234; 202 .079
SECONDARY
Tobacco Abstinence, Self-report
234; 202 .079
SECONDARY
Engagement in Cessation Treatment
434; 319 <.0001 sig
SECONDARY
Engagement in Cessation Treatment
434; 319 <.0001 sig
SECONDARY
Self-reported Continuous Tobacco Abstinence Since Hospital Discharge
120; 91 .033 sig

Summary

This randomized controlled trial will compare the effectiveness of two models of post-discharge tobacco cessation treatment for adult smokers admitted to 3 U.S. hospitals.

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or older
  • Current cigarette smoker (>=1 cigarette in the week before admission and >=1 cigarette/day when smoking at a baseline rate in the month prior to admission)
  • Admitted to a study hospital
  • Seen by hospital smoking counselor during inpatient stay
  • Plans to try to quit smoking after hospital discharge

Exclusion Criteria

  • Inability to give informed consent or participate in counseling due to serious cognitive or psychiatric disorder (e.g., dementia, psychosis)
  • Life expectancy <12 months
  • Medical instability
  • No reliable telephone access or inability to use telephone
  • Non-English speaking
  • Pregnant, breastfeeding, to planning to become pregnant in the next 6 months.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03603496). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search